X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2017 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare Novartis with WYETH LTD - Equitymaster
  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

NOVARTIS vs WYETH LTD - Comparison Results

NOVARTIS    Change

Novartis is a 76% subsidiary of Novartis AG - Switzerland and has a countrywide presence in the healthcare business. While pharmaceuticals contributes 70% to total revenues (FY10), generics (6%), consumer healthcare i.e. OTC (14%) and animal health (... More

WYETH LTD 
   Change

Wyeth Limited is the 51% subsidiary of Wyeth, US and is the sixth largest company among multinationals with revenues of Rs 2.9 bn in FY07. The company derives its revenues from pharmaceutical and OTC segments with focus on various therapeutic areas s... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    NOVARTIS WYETH LTD NOVARTIS/
WYETH LTD
 
P/E (TTM) x 346.4 27.7 1,249.6% View Chart
P/BV x 17.1 5.3 318.8% View Chart
Dividend Yield % 1.7 1.3 132.9%  

Financials

 NOVARTIS   WYETH LTD
EQUITY SHARE DATA
    NOVARTIS
Mar-16
WYETH LTD
Mar-13
NOVARTIS/
WYETH LTD
5-Yr Chart
Click to enlarge
High Rs9821,044 94.0%   
Low Rs556818 68.0%   
Sales per share (Unadj.) Rs252.9298.6 84.7%  
Earnings per share (Unadj.) Rs62.157.2 108.6%  
Cash flow per share (Unadj.) Rs63.358.4 108.4%  
Dividends per share (Unadj.) Rs10.0017.00 58.8%  
Dividend yield (eoy) %1.31.8 71.2%  
Book value per share (Unadj.) Rs363.6249.5 145.8%  
Shares outstanding (eoy) m31.9622.72 140.7%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x3.03.1 97.5%   
Avg P/E ratio x12.416.3 76.1%  
P/CF ratio (eoy) x12.215.9 76.2%  
Price / Book Value ratio x2.13.7 56.7%  
Dividend payout %16.129.7 54.2%   
Avg Mkt Cap Rs m24,58021,157 116.2%   
No. of employees `0000.80.5 152.8%   
Total wages/salary Rs m1,801400 450.3%   
Avg. sales/employee Rs Th10,748.913,787.4 78.0%   
Avg. wages/employee Rs Th2,395.2813.0 294.6%   
Avg. net profit/employee Rs Th2,641.12,643.3 99.9%   
INCOME DATA
Net Sales Rs m8,0836,783 119.2%  
Other income Rs m829353 235.2%   
Total revenues Rs m8,9137,136 124.9%   
Gross profit Rs m2341,617 14.5%  
Depreciation Rs m3727 138.0%   
Interest Rs m26 32.7%   
Profit before tax Rs m1,0251,938 52.9%   
Minority Interest Rs m00-   
Prior Period Items Rs m170-   
Extraordinary Inc (Exp) Rs m1,696-5 -33,260.8%   
Tax Rs m752632 118.9%   
Profit after tax Rs m1,9861,301 152.7%  
Gross profit margin %2.923.8 12.2%  
Effective tax rate %73.432.6 224.9%   
Net profit margin %24.619.2 128.2%  
BALANCE SHEET DATA
Current assets Rs m12,6786,984 181.5%   
Current liabilities Rs m2,4332,056 118.3%   
Net working cap to sales %126.772.6 174.5%  
Current ratio x5.23.4 153.4%  
Inventory Days Days3399 32.9%  
Debtors Days Days2224 93.9%  
Net fixed assets Rs m69244 28.3%   
Share capital Rs m160227 70.3%   
"Free" reserves Rs m11,4605,441 210.6%   
Net worth Rs m11,6215,668 205.0%   
Long term debt Rs m025 0.0%   
Total assets Rs m14,4007,901 182.2%  
Interest coverage x570.5353.3 161.5%   
Debt to equity ratio x00 0.0%  
Sales to assets ratio x0.60.9 65.4%   
Return on assets %13.816.5 83.5%  
Return on equity %17.122.9 74.5%  
Return on capital %23.634.0 69.3%  
Exports to sales %0.70.2 341.3%   
Imports to sales %18.636.3 51.2%   
Exports (fob) Rs m6015 406.8%   
Imports (cif) Rs m1,5032,465 61.0%   
Fx inflow Rs m18615 1,225.7%   
Fx outflow Rs m1,8212,677 68.0%   
Net fx Rs m-1,635-2,662 61.4%   
CASH FLOW
From Operations Rs m2,531923 274.1%  
From Investments Rs m-8,270317 -2,609.6%  
From Financial Activity Rs m-386-481 80.2%  
Net Cashflow Rs m-6,125759 -806.8%  

Share Holding

Indian Promoters % 0.0 0.0 -  
Foreign collaborators % 75.0 51.1 146.8%  
Indian inst/Mut Fund % 2.0 11.3 17.7%  
FIIs % 1.6 7.2 22.2%  
ADR/GDR % 0.0 0.0 -  
Free float % 21.5 30.4 70.7%  
Shareholders   41,647 21,978 189.5%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare NOVARTIS With:   SANOFI INDIA  TORRENT PHARMA  FRESENIUS KABI ONCO.  CIPLA  ASTRAZENECA PHARMA  

Compare NOVARTIS With:   ADCOCK INGRAM (S. Africa)  MYLAN (US)  ACTAVIS (US)  TEVA PHARMA (Israel)  



Today's Market

Sensex Finishes on a Flat Note; Coal India Stock Rallies 4.2%(Closing)

Indian share markets finished some selling pressure in the final hour of trade to finish flat amid weak European markets.

Related Views on News

Sun Pharma: Bottomline Slips into the Red Amidst Challenging Environment (Quarterly Results Update - Detailed)

Aug 14, 2017

A challenging environment and one-time expense pushes Sun Pharma into a loss in the first quarter.

Lupin: Bigger Challenges or Bigger Margin of Safety? (Quarterly Results Update - Detailed)

Aug 14, 2017

GST impact coupled with price erosion in US leads to lower profits for the quarter.

Dr Reddy's: US Pressure Continues to Haunt (Quarterly Results Update - Detailed)

Aug 8, 2017

Profits plunge due to higher raw material costs.

Biocon: Lower Licensing Income Leads to Muted Growth for the Quarter (Quarterly Results Update - Detailed)

Jun 23, 2017

Net Profit lower due to exceptional items in the previous year.

The Power of 5 Minutes (The 5 Minute Wrapup)

Jun 16, 2017

Here's what you can expect from The 5 Minute Wrapup in the coming months and years.

More Views on News

Most Popular

Demonetisation Barely Made Any Difference to Tax Collections(Vivek Kaul's Diary)

Aug 7, 2017

The data tells us quite a different story from the one the government is trying to project.

Proxy Plays: A Smart Way to Bet on 'Off Limits' Companies(The 5 Minute Wrapup)

Aug 4, 2017

The small-cap space is full of small players that are clear proxies to great growth stories and Indian megatrends.

Should You Invest In Bharat-22 ETF? Know Here...(Outside View)

Aug 8, 2017

Bharat-22 is one of the most diverse ETFs offered so far by the Government. Know here if you should invest...

Signs of Life in the India VIX(Daily Profit Hunter)

Aug 12, 2017

The India VIX is up 36% in the last week. Fear has gone up but is still low by historical standards.

7 Financial Gifts For Your Sister This Raksha Bandhan(Outside View)

Aug 7, 2017

Raksha Bandhan signifies the brother-sister bond. Here are 7 thoughtful financial gifts for sisters...

More

Become A Smarter Investor In
Just 5 Minutes

Multibagger Stocks Guide 2017
Get our special report, Multibagger Stocks Guide (2017 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

NOVARTIS SHARE PRICE


Aug 17, 2017 (Close)

TRACK NOVARTIS

  • Track your investment in NOVARTIS with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

NOVARTIS - JUBILANT LIFE SCIENCES COMPARISON

COMPARE NOVARTIS WITH

MARKET STATS